A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer

NCT07383922 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

524

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: FG-M108
DRUG: nab paclitaxel
DRUG: Gemcitabine (GEM)
DRUG: Placebo for FG-M108

Sponsor

FutureGen Biopharmaceutical (Beijing) Co., Ltd